1.54
Akebia Therapeutics Inc (AKBA) 最新ニュース
How forex fluctuations impact Akebia Therapeutics Inc. (AX9) stockWeekly Loss Report & Reliable Intraday Trade Plans - newser.com
How Akebia Therapeutics Inc. stock compares to market leadersPortfolio Risk Summary & Growth Focused Entry Point Reports - newser.com
What analyst consensus implies for Akebia Therapeutics Inc. (AX9) stockCEO Change & AI Forecasted Entry/Exit Points - newser.com
Is Akebia Therapeutics Inc. stock cheap at current valuationBond Market & Weekly High Potential Stock Alerts - newser.com
Live market analysis of Akebia Therapeutics Inc.Portfolio Gains Report & Real-Time Sentiment Analysis - newser.com
How Akebia Therapeutics Inc. (AX9) stock gains from tech spendingTrade Entry Report & Free Verified High Yield Trade Plans - newser.com
How Akebia Therapeutics Inc. (AX9) stock behaves in tightening cyclesMarket Volume Summary & Expert Curated Trade Setups - newser.com
Signal strength of Akebia Therapeutics Inc. stock in tech scannersJuly 2025 Opening Moves & Low Risk Entry Point Guides - newser.com
Is Akebia Therapeutics Inc. stock a safe investment in uncertain markets2025 AllTime Highs & Low Drawdown Investment Strategies - newser.com
How strong dollar benefits Akebia Therapeutics Inc. (AX9) stock - newser.com
Tools to assess Akebia Therapeutics Inc.’s risk profileJuly 2025 Weekly Recap & Stock Portfolio Risk Control - newser.com
Brokerages Set Akebia Therapeutics, Inc. (NASDAQ:AKBA) Price Target at $6.00 - Defense World
This trade activity should not be overlooked: Akebia Therapeutics Inc (AKBA) - Setenews
Levi & Korsinsky Announces an Investigation on Behalf of Akebia Therapeutics, Inc. (AKBA) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
AKBA: Vafseo's expanding access and strong clinical data position it for standard of care in dialysis - TradingView
Akebia Therapeutics, Inc. Announces Amendment to License Agreement for Drug Supply and Manufacturing Rights - MarketScreener
Akebia Therapeutics amends license agreement with Medice for Vafseo supply - Investing.com
Akebia Therapeutics amends license agreement with Medice for Vafseo supply By Investing.com - Investing.com South Africa
Akebia Therapeutics Inc says on Nov 12, co and Medice amend license agreement - MarketScreener
Analyzing Akebia Therapeutics Inc. with risk reward ratio charts2025 Trading Recap & Reliable Breakout Stock Forecasts - newser.com
Akebia Therapeutics Shares Extend Decline Amid Analyst Downgrades - Ad-hoc-news.de
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
FY2025 Earnings Forecast for AKBA Issued By Leerink Partnrs - MarketBeat
Akebia Therapeutics Inc. stock retracement – recovery analysisMarket Performance Recap & Growth Oriented Trading Recommendations - newser.com
Shareholders Alert: Investigation Into Akebia Therapeutics, Inc. (AKBA)Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire
How Akebia Therapeutics Inc. stock reacts to job market data2025 Price Targets & Community Consensus Picks - newser.com
Why Akebia Therapeutics Inc. (AX9) stock attracts wealthy investorsExit Point & AI Driven Price Predictions - newser.com
How rising interest rates impact Akebia Therapeutics Inc. stockQuarterly Profit Report & Accurate Technical Buy Alerts - newser.com
大文字化:
|
ボリューム (24 時間):